Quantitative Stress Echocardiography to Diagnose Myocardial Ischaemia (DEVISE)
Development, Validation and Implementation of a New Quantitative Stress Echocardiographic Test for Myocardial Ischaemia
Sponsor: Danderyd Hospital
This observational or N/A phase trial investigates Ischemia, Myocardial and is currently ongoing. Danderyd Hospital leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Feb 2023 — Jul 2024 [monthly]
Unknown Status
-
Mar 2022 — Feb 2023 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Mar 2022 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Dec 2019 — Jan 2021 [monthly]
Recruiting
-
Oct 2018 — Dec 2019 [monthly]
Recruiting
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Danderyd Hospital
- Hull University Teaching Hospitals NHS Trust
- Universitaire Ziekenhuizen KU Leuven
- Universitat Pompeu Fabra
- University Hospital of Wales
For direct contact, visit the study record on ClinicalTrials.gov .